Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Amplia Therapeutics Ltd. (INNMF)
OTHER OTC:INNMF
Holding INNMF?
Track your performance easily
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Dec 20, 2024 | Jane Bell Non Executive,director | xxxxxxxxxxxxx | AU$80000 |
| Dec 20, 2024 | Christopher John Burns Managing Director & Chief Executive Officer | xxxxxxxxxxxxx | AU$40000 |
| Dec 20, 2024 | Warwick Bonner Tong Chairman,director | xxxxxxxxxxxxx | AU$80000 |
| Dec 20, 2024 | Robert J Peach Non Executive,director | xxxxxxxxxxxxx | AU$125000 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Amplia Therapeutics Ltd. (INNMF)?
Currently, no data Available
What percentage of Amplia Therapeutics Ltd. (INNMF) stock is held by institutional investors?
Currently, no data Available
What percentage of Amplia Therapeutics Ltd. (INNMF) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Amplia Therapeutics Ltd. (INNMF)?
Currently, no data Available
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.